Ferrante Karen Jean 4
4 · Cogent Biosciences, Inc. · Filed Apr 3, 2025
Insider Transaction Report
Form 4
Ferrante Karen Jean
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-04-01+3,788→ 3,788 totalExercise: $5.79From: 2025-04-01Exp: 2035-04-01→ Common Stock (3,788 underlying)
Footnotes (1)
- [F1]The option award was issued to the Reporting Person, who elected to take shares in lieu of cash compensation for services as a director, pursuant to the Issuer's non-employee director compensation plan. The number of options granted was determined by dividing the cash compensation otherwise payable with respect to the quarter by the Black-Scholes value of a single option calculated as of the date of the grant.